GlassScriptPhysician profile
Tamara S Crowell
NPI 1497909451
$13,351.74
in general payments reported to CMS, 2019-2025
60 companies · $2,829 in 2025
The $2,829 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $120 · 2022: $3,163 · 2023: $3,738 · 2024: $3,502 · 2025: $2,829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,971 · Education: $98.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,970.88 |
| Education | $98.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,340.43 | 2022-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals LP | $1,262.59 | 2022-2025 | Airsupra, Farxiga, Lokelma |
| Otsuka America Pharmaceutical, INC. | $1,225.12 | 2022-2025 | Jynarque, Rexulti, Nuedexta |
| Abbvie INC. | $1,013.23 | 2022-2025 | |
| Abbott Laboratories | $896.01 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Novo Nordisk INC | $822.00 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $789.97 | 2022-2025 | Evenity, Repatha, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $690.88 | 2022-2025 | |
| Lilly USA, LLC | $588.89 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $529.19 | 2022-2025 | Jardiance |
| Corcept Therapeutics | $433.11 | 2022-2025 | Korlym |
| Takeda Pharmaceuticals U.S.A., INC. | $422.75 | 2022-2025 | Glassia |
| Merck Sharp & Dohme LLC | $251.10 | 2023-2025 | Verquvo, Belsomra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $247.78 | 2022-2025 | Xifaxan, Trulance |
| Sanofi-Aventis U.S. LLC | $223.24 | 2022-2023 |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Crowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.